FDA Rejects MDMA for Mental Health Treatment After Identifying Flawed Study Data
CCHR welcomes the FDA’s decision to disapprove the hallucinogenic drug, MDMA (Ecstasy) saying if approved, it would have fueled a planned $12 billion industry to…
Tag Archives: psychiatric drugs
Foster Care Children Vulnerable to Maltreatment, Including Psychotropic Drug Use
CCHR, a mental health industry watchdog, praises OIG report highlighting states’ failed oversight of foster children’s treatment and calls for immediate action to address ongoing…
High Antidepressant Use Calls for a “De-Prescribing” De-Escalation Policy
CCHR calls for the U.S. to adopt the recent UK recommendation to reduce antidepressant use. With over 45 million Americans currently on these drugs, which…
Study Questions Serious Flaws in $35 Million Antidepressant Research
CCHR says millions of taxpayer dollars are wasted on psychotropic drug research later found to be flawed and harmful to consumers By CCHR InternationalThe Mental…
“Overdosing” America’s Youth—Dangerous Trend in Antidepressant Prescribing
CCHR raises concerns about antidepressant prescribing to children that could drive up suicides, according to new studies. By CCHR InternationalThe Mental Health Industry WatchdogMarch 1,…